Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00588_DB00872_nanopub.RA54QAjMbIt8m2oqdRP6sjsT9nzcm8R0qPJNUZVKFeXSs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00588_DB00872 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00588_DB00872 label "DDI between Fluticasone Propionate and Conivaptan - CYP3A4 Inhibitors (Strong) may increase the serum concentration of Fluticasone (Oral Inhalation). Concurrent use of orally inhaled fluticasone with strong CYP3A4 inhibitors is not recommended. [drugbank_resource:DB00588_DB00872]" assertion.
- drugbank_resource:DB00588_DB00872 identifier "drugbank_resource:DB00588_DB00872" assertion.
- drugbank_resource:DB00588_DB00872 title "DDI between Fluticasone Propionate and Conivaptan - CYP3A4 Inhibitors (Strong) may increase the serum concentration of Fluticasone (Oral Inhalation). Concurrent use of orally inhaled fluticasone with strong CYP3A4 inhibitors is not recommended." assertion.
- drugbank:DB00872 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00588_DB00872 assertion.
- drugbank:DB00588 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00588_DB00872 assertion.